Neuronetics STIM Clinical Services — Cost of Goods Sold
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Neuronetics in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.
The official record: Neuronetics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Neuronetics's clinical services — cost of goods sold.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Neuronetics's clinical services — cost of goods sold?
- Neuronetics (STIM) reported clinical services — cost of goods sold of $15.44M in Q1 2026.
- How has Neuronetics's clinical services — cost of goods sold changed year-over-year?
- Neuronetics's clinical services — cost of goods sold increased by 18.0% year-over-year, from $13.09M to $15.44M.
- What does clinical services — cost of goods sold mean?
- This metric captures the direct costs associated with providing clinical services, including labor, materials, and overhead directly attributable to service delivery. Monitoring this helps evaluate the direct cost efficiency of the clinical operations segment.